Format

Send to

Choose Destination
Biochem Soc Trans. 2013 Dec;41(6):1583-7. doi: 10.1042/BST20130140.

Endocannabinoid signalling in Alzheimer's disease.

Author information

1
*Sheffield Institute for Translational Neuroscience (SITraN), 385a Glossop Road, University of Sheffield, Sheffield S10 2HQ, U.K.

Abstract

The ECs (endocannabinoids) AEA (anandamide) and 2-AG (2-arachidonoylglycerol) and their lipid congeners OEA (N-oleoylethanolamide) and PEA (N-palmitoylethanolamide) are multifunctional lipophilic signalling molecules. The ECs, OEA and PEA have multiple physiological roles including involvement in learning and memory, neuroinflammation, oxidative stress, neuroprotection and neurogenesis. They have also been implicated in the pathology of, or perhaps protective responses to, neurodegenerative diseases. This is particularly the case with Alzheimer's disease, the most common age-related dementia associated with impairments in learning and memory accompanied by neuroinflammation, oxidative stress and neurodegeneration. The present mini-review examines the evidence supporting the roles that ECs appear to play in Alzheimer's disease and the potential for beneficial therapeutic manipulation of the EC signalling system.

PMID:
24256258
DOI:
10.1042/BST20130140
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center